Trusted Resources: Evidence & Education
Scientific literature and patient education texts
The association of sickle cell-related stigma with physical and emotional symptoms in patients with sickle cell pain
source: The Journal of Pain
year: 2016
authors: M. Ezenwa, Y. Yao, R. Molokie, Z. Wang, M. Suarez, Z. Zhao, J. Carrasco, V. Angulo, D. Shuey, K. Roach, G. Oraifo, D. Wilkie
summary/abstract:Stigma is associated with adverse health outcomes. Patients with sickle cell disease (SCD) experience stigma because of their minority status, frequency of their acute healthcare utilization, and chronic use of opioids for pain management. There is minimal research on the association of sickle cell-related stigma (stigma) with physical and emotional symptoms in adult patients with SCD. This descriptive comparative study was conducted to determine the association of stigma with physical (pain and fatigue) and emotional (anger, anxiety, and depression) symptoms in patients with SCD. Patients (N=52, mean age 36.1±10.9 years [ranged from 22-74 years], 96% African-American, 56% female) recruited between March-November 2015 completed PAINReportIt, a computerized pain measure, demographic questions, the Sickle Cell Stigma Scale, and the PROMIS measures (anger, anxiety, and depression). Data were analyzed using the statistical software R. The mean scores for the study variables were: Stigma (2.3±1.0); average pain intensity (4.0±2.3); fatigue (56.3±9.5); anger (51.1±12.6); anxiety (52.8±9.3); and depression (51.8±10.2). Our comparative analysis results indicated that there were statistically significant differences between Low Stigma (<=2, n=26) and High Stigma (>2, n=26) groups on study variables. Patients who reported high stigma were more likely to report increased: fatigue (p<.001); anger (p<.001); anxiety (p<.001); and depression (p<.001) than patients who reported low stigma. Patient who reported high stigma and those who reported low stigma did not differ on average pain intensity (p=.07). Findings provide preliminary evidence of the association of stigma with fatigue, anger, anxiety, and depression in patients with SCD. Results from future studies will provide additional evidence to better understand the influence of stigma on physical and emotional symptoms in patients with SCD, and likely inform future intervention studies to decrease stigma in this vulnerable pain patient population.
organization: University of Illinois at ChicagoDOI: 10.1016/j.jpain.2016.01.060
read more
Related Content
-
Citizens for Quality Sickle Cell CareThe New England Sickle Cell Institute at...
-
Biochemical surrogate markers of hemolysis do not correlate with directly measured erythrocyte survival in sickle ce...Hemolysis is a key feature of sickle cel...
-
Safety and early hints of benefit seen in phase 1b trial of PF-04447943Sickle cell disease (SCD) patients were ...
-
Society of Pediatric Psychology Fall Virtual ConferenceSeptember 29, 2023 | 10 a.m. to 5 p.m. E...
-
Healthwell Foundation Sickle Cell Disease FundThe HealthWell Foundation®, an independ...
-
Robust Clinical and Laboratory Response to Hydroxyurea Using Pharmacokinetically Guided Dosing for Young Children Wi...Hydroxyurea is FDA-approved and now incr...
-
Dana-Farber/Boston Children’s Cancer and Blood Disorders CenterSpecialists in the Sickle Cell Disease P...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.